Infosys (INFY) CEO Salil Parekh receives new performance and ESG equity grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Infosys Ltd CEO & Managing Director Salil S. Parekh received three equity award grants under company plans. On May 2, 2026, he was granted derivative awards for 43,138 shares under a 2019 annual performance equity grant, 13,273 shares under a performance equity grant tied to ESG metrics, and 230,621 shares under a 2015 plan annual performance equity grant. Each award relates to an equal number of underlying Indian Equity Shares with an exercise price of INR 5.00 per share and expirations between June 1 and July 31, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Parekh Salil S.
Role
CEO & Managing Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Annual Performance Equity Grant - 2015 Plan | 230,621 | $0.00 | -- |
| Grant/Award | Performance Equity Grant (ESG Metrics) - 2015 Plan | 13,273 | $0.00 | -- |
| Grant/Award | 2019 Annual Performance Equity Grant | 43,138 | $0.00 | -- |
Holdings After Transaction:
Annual Performance Equity Grant - 2015 Plan — 230,621 shares (Direct, null);
Performance Equity Grant (ESG Metrics) - 2015 Plan — 13,273 shares (Direct, null);
2019 Annual Performance Equity Grant — 43,138 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
2019 performance grant size: 43,138 derivative units
ESG metrics grant size: 13,273 derivative units
2015 plan performance grant size: 230,621 derivative units
+2 more
5 metrics
2019 performance grant size
43,138 derivative units
2019 Annual Performance Equity Grant on May 2, 2026
ESG metrics grant size
13,273 derivative units
Performance Equity Grant (ESG Metrics) - 2015 Plan on May 2, 2026
2015 plan performance grant size
230,621 derivative units
Annual Performance Equity Grant - 2015 Plan on May 2, 2026
Exercise price
INR 5.0000 per share
Exercise price for each underlying Indian Equity Share
Expiration range
June 1–July 31, 2026
Expiration dates of reported derivative awards
Key Terms
Performance Equity Grant, Performance Equity Grant (ESG Metrics), Indian Equity Shares, exercise price, +1 more
5 terms
Performance Equity Grant financial
"Annual Performance Equity Grant - 2015 Plan"
Performance Equity Grant (ESG Metrics) financial
"Performance Equity Grant (ESG Metrics) - 2015 Plan"
exercise price financial
"The exercise price is Indian Rupee (INR)."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did Infosys (INFY) CEO Salil Parekh report in this Form 4 filing?
Salil S. Parekh reported receiving three equity award grants linked to Infosys shares. These derivative awards are performance-based grants under company plans and give him the right to acquire specific numbers of Indian Equity Shares at a fixed exercise price.
What is the exercise price of Salil Parekh’s new Infosys equity awards?
Each derivative award carries an exercise price of 5.0000 in Indian Rupees per underlying share. This fixed price applies to the Indian Equity Shares that can be acquired upon exercise, according to the footnote clarifying the currency as INR.
When do Salil Parekh’s newly granted Infosys equity awards expire?
The reported derivative awards have expiration dates between June 1, 2026 and July 31, 2026. Each grant specifies its own expiration date, setting the latest date by which the underlying Indian Equity Shares can be acquired at the stated exercise price.